Growth hormone research peptides in Canada
GHRH analogues and ghrelin receptor agonists, studied for their effect on growth hormone release. CJC-1295 with and without DAC, ipamorelin, sermorelin and tesamorelin, singly and as the CJC-1295 + ipamorelin blend. Tesamorelin is the one with an authorized Canadian product behind the molecule.

CJC-1295 (no DAC)
Growth hormone-releasing hormone (GHRH) analogue
from $38.00HPLC · CoA
Add 2 more to save 4%

CJC-1295 with DAC
Long-acting growth hormone-releasing hormone (GHRH) analogue
from $52.00HPLC · CoA
Add 2 more to save 4%

Ipamorelin
Growth hormone secretagogue (ghrelin receptor agonist)
from $62.00HPLC · CoA
Add 2 more to save 4%

Tesamorelin
Growth hormone-releasing hormone (GHRH) analogue
from $61.50HPLC · CoA
Add 2 more to save 4%
How these compare
| Compound | Class | Sizes | From |
|---|---|---|---|
| CJC-1295 (no DAC) | Growth hormone-releasing hormone (GHRH) analogue | 10 mg | $38.00 |
| CJC-1295 with DAC | Long-acting growth hormone-releasing hormone (GHRH) analogue | 5 mg · 10 mg | $52.00 |
| Ipamorelin | Growth hormone secretagogue (ghrelin receptor agonist) | 10 mg | $62.00 |
| Tesamorelin | Growth hormone-releasing hormone (GHRH) analogue | 5 mg · 10 mg | $61.50 |
| CJC-1295 + Ipamorelin | Two-peptide research blend: a GHRH analogue and a ghrelin receptor (GHS-R) agonist | 10 mg | $69.00 |
